Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)

[1]  D. Schadendorf,et al.  Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model , 2011, Proceedings of the National Academy of Sciences.

[2]  R. Zubarev,et al.  Proteomic Pathway Analysis Reveals Inflammation Increases Myeloid-Derived Suppressor Cell Resistance to Apoptosis* , 2010, Molecular & Cellular Proteomics.

[3]  P. De Baetselier,et al.  Myeloid‐derived suppressor cells in parasitic infections , 2010, European journal of immunology.

[4]  R. Zubarev,et al.  Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. , 2010, Blood.

[5]  Yu-Ping 林裕萍Lin,et al.  Aberrant integrin activation induces p38 MAPK phosphorylation resulting in suppressed Fas-mediated apoptosis in T cells: Implications for rheumatoid arthritis , 2009 .

[6]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells1 , 2009, The Journal of Immunology.

[7]  P. Sinha,et al.  Inflammation enhances myeloid‐derived suppressor cell cross‐talk by signaling through Toll‐like receptor 4 , 2009, Journal of leukocyte biology.

[8]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.

[9]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[10]  D. Foell,et al.  Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.

[11]  W. Nacken,et al.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.

[12]  O. Janssen,et al.  Storage, expression and function of Fas ligand, the key death factor of immune cells. , 2008, Current medicinal chemistry.

[13]  E. Wingender,et al.  Identification of dominant signaling pathways from proteomics expression data. , 2008, Journal of proteomics.

[14]  L. Coussens,et al.  Polarized immune responses differentially regulate cancer development , 2008, Immunological reviews.

[15]  W. Grizzle,et al.  Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice , 2007, Mechanisms of Ageing and Development.

[16]  J. Leips,et al.  Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.

[17]  V. Kuchroo,et al.  CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[18]  Yufang Shi,et al.  Apoptosis signaling pathways and lymphocyte homeostasis , 2007, Cell Research.

[19]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[20]  J. Ochoa,et al.  CD11b+/Gr-1+ Myeloid Suppressor Cells Cause T Cell Dysfunction after Traumatic Stress1 , 2006, The Journal of Immunology.

[21]  J. Leips,et al.  Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression1 , 2006, The Journal of Immunology.

[22]  S. Segal,et al.  CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells1 , 2005, The Journal of Immunology.

[23]  P. Sinha,et al.  Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. , 2005, Cancer research.

[24]  S. Dubinett,et al.  Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma , 2005, The Journal of experimental medicine.

[25]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[26]  P. Sinha,et al.  Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease1 , 2005, The Journal of Immunology.

[27]  Fredrik Melander,et al.  p38-MAPK Signals Survival by Phosphorylation of Caspase-8 and Caspase-3 in Human Neutrophils , 2004, The Journal of experimental medicine.

[28]  Ying E. Zhang,et al.  TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses , 2002 .

[29]  D. Gabrilovich,et al.  Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells. , 2001, Human immunology.

[30]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[31]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[32]  M. Grusby,et al.  Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma1 , 2000, The Journal of Immunology.

[33]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[34]  V. Kuchroo,et al.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. , 2007, Journal of immunology.

[35]  Li J. Yu,et al.  TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. , 2002, The EMBO journal.

[36]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.